Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2245035 in Respiratory Allergies
NCT01788813Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2245035 in allergic rhinitis (AR), asthma, sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
GSK2245035
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on NCT01788813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01788813.